Medtronic has launched the Achieve Mapping Catheter, an intra-cardiac electrophysiology recording catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation (PAF) in Europe.
Medtronic said that the Achieve Mapping Catheter has a distal mapping section with a circular loop which is available in two loop diameters (15mm and 20mm) and is deployed through the Arctic Front guidewire lumen, allowing for a single transseptal puncture.
The catheter features eight evenly spaced electrodes on a loop, enabling physicians to map electrical conduction between the left atrium and pulmonary veins.
Additionally, the catheter allows for assessment of pulmonary vein potentials both before and after cryoablation and also helps physicians assess time-to-effect during cryoablation.
The catheter technology, which has received the CE (Conformite Europeenne) Mark, is designed to be used with the Medtronic Arctic Front Cardiac CryoAblation Catheter System, offering an approach to the minimally invasive procedure.
Medtronic AF Solutions division vice president and general manager Reggie Groves said the Achieve Mapping Catheter offers an enhancement to the Arctic Front system – presenting physicians with a simplified approach to pulmonary vein isolation.